SC 13G | 2016-01-21 | Man Group plc | Avalanche Biotechnologies, Inc. | 1,375,602 | 5.3% | EDGAR |
SC 13G | 2015-07-14 | INTEGRATED CORE STRATEGIES (US) LLC | Avalanche Biotechnologies, Inc. | 685,892 | 2.7% | EDGAR |
SC 13G/A | 2015-02-17 | Flynn James E | Avalanche Biotechnologies, Inc. | 960,384 | 4.3% | EDGAR |
SC 13G | 2015-02-13 | Venrock Healthcare Capital Partners II, L.P. | Avalanche Biotechnologies, Inc. | 1,382,735 | 6.2% | EDGAR |
SC 13G | 2015-02-11 | Chalberg Thomas W. | Avalanche Biotechnologies, Inc. | 791,401 | 3.0% | EDGAR |
SC 13G | 2015-02-03 | WILF ZYGMUNT | Avalanche Biotechnologies, Inc. | - | - | EDGAR |
SC 13G | 2014-12-10 | FMR LLC | Avalanche Biotechnologies, Inc. | 3,370,545 | 15.0% | EDGAR |
SC 13G | 2014-08-07 | REGENERON PHARMACEUTICALS INC | Avalanche Biotechnologies, Inc. | 1,809,098 | 8.1% | EDGAR |
SC 13G | 2014-08-05 | Flynn James E | Avalanche Biotechnologies, Inc. | 1,543,394 | 6.9% | EDGAR |